Haleon plc
HLN
Classement en actions
#13620
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Prix de l'action
$5.14
Capitalisation boursière
$452.02M
Changement (1 jour)
1.07%
Changement (1 an)
9.12%
Pays
GB
Échange Haleon plc (HLN)
Catégorie
Healthcare
Capitalisation boursière de Haleon plc(HLN)
Capitalisation boursière: $452.02M
En October 2026, Haleon plc a une capitalisation boursière de $452.02M. Cela fait de Haleon plc la 13620th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Haleon plc du 2022 au 2026
HLN par rapport au top 5 des plus populaires stocks
